Global edition · EN
More than 1,600 AI-enabled devices are authorised in the US. What the market offers patients and clinicians, what the evidence shows and the rules by jurisdiction.
v1.5 · 40 pages · 27 Oct 2026 · Edition
Research populations, geographical scope, source dates and limitations are stated in this edition. The research catalogue and the interactive website catalogue cover different populations.
Good_AI_Prism_Sector_Brief_Health_Life_Sciences_EN_v1.5_20261027.pdf · Edition 1.5
Research populations, geographical scope, source dates and limitations are stated in this edition. The research catalogue and the interactive website catalogue cover different populations.
Research method and catalogue coverage →
THE FINDING AT A GLANCE
More than 1,600 AI-enabled devices are authorised in the US. What the market offers patients and clinicians, what the evidence shows and the rules by jurisdiction.
Read the sources and scope on the figure. The graphic is a separate format of this publication; it does not change the study’s research population.
Choose the readers and rights for this exact edition.
Global edition · EN · v1.5
€99 net · one-time
Enquire about this licence →
ETHORITY®424c05d51c54f8dcb2a28bdbaef50bdd44ea6fe4ee158d0cf538a8b621bce64c Sten Franke & ETHORITY
© 2026 ETHORITY & STEN.AI LLC. Text and exhibits may be quoted with source attribution. Good AI Prism artwork: CC BY-NC-ND 4.0 (artwork only; data, software and third-party marks not covered); commercial use by licence on request: https://ethority.ai/products/research-licensing
Produced with AI assistance: research compilation, drafting, German and English language work, layout and rendering were carried out with AI systems (OSIRIS) under ETHORITY editorial direction (Sten Franke). Figures carry their cited sources.
Metadata identifies this edition. The SHA-256 identifies its exact file bytes.
Global edition · EN
AI-supported breast screening cut screen-reading workload by 44%. The first late-stage trials, the evidence and the money in drug discovery, cancer care and ageing science.
Version 1.7 · 40 pages
Open the study →
Global edition · EN
The world will be short of 11.1 million health workers by 2030. How health systems and long-term care use AI and robotics to give time back to care.
Version 1.5 · 23 pages
Open the study →
Global edition · EN
The Good AI Prism helps you find useful AI and compare the evidence behind your options. For organisations already using AI, the question is moving from whether to use AI to which AI, how safely and whether it pays. This Global edition brings together 961 AI offerings across 24 topic areas, 8 data types and 6 technology layers, with sources, dates and limits to guide your next decision.
Version 2.6 · 90 pages
Open the study →